These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9085139)

  • 1. Liposomes for drug targeting in the lymphatic system.
    Hirnle P
    Hybridoma; 1997 Feb; 16(1):127-32. PubMed ID: 9085139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug depots in lymph nodes: which carrier is most appropriate?
    Hirnle P
    J Microencapsul; 1991; 8(1):103-19. PubMed ID: 1880687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.
    Chaudhary S; Garg T; Murthy RS; Rath G; Goyal AK
    J Drug Target; 2014 Dec; 22(10):871-82. PubMed ID: 25148607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guaiazulene in orodental surgery].
    Iwasa T; Sato O; Mitsuhashi J; Shima Y; Hayashi M
    Shikai Tenbo; 1983 Sep; 62(3):609-20. PubMed ID: 6582618
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicity and antitumor activity of niosomal bleomycin in tumor bearing mice.
    Naresh RA; Udupa N; Devi PU
    Indian J Exp Biol; 1996 Aug; 34(8):764-72. PubMed ID: 8979482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targeting of liposomal nano-particles to lymphatic system.
    Cuong NV; Hsieh MF
    Curr Cancer Drug Targets; 2011 Feb; 11(2):147-55. PubMed ID: 21158721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
    Fenske DB; Cullis PR
    Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.
    Cai S; Yang Q; Bagby TR; Forrest ML
    Adv Drug Deliv Rev; 2011 Sep; 63(10-11):901-8. PubMed ID: 21712055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on liposome-encapsulated carboquone. III. Enhancement of lymphatic transport of carboquone by encapsulation.
    Hisaoka M; Tsukada K; Morioka T
    J Pharmacobiodyn; 1982 Jan; 5(1):27-33. PubMed ID: 7077519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate.
    Zhang H; Wang ZY; Gong W; Li ZP; Mei XG; Lv WL
    Int J Pharm; 2011 Jul; 414(1-2):56-62. PubMed ID: 21596128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ dose amplification by apoptosis-targeted drug delivery.
    Wang K; Na MH; Hoffman AS; Shim G; Han SE; Oh YK; Kwon IC; Kim IS; Lee BH
    J Control Release; 2011 Sep; 154(3):214-7. PubMed ID: 21763738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on gelatin microspheres-in-oil emulsion of pingyangmycin].
    Li HS; Wei SL; Lu W
    Yao Xue Xue Bao; 1995; 30(5):390-4. PubMed ID: 7544945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy.
    Kong M; Hou L; Wang J; Feng C; Liu Y; Cheng X; Chen X
    Chem Commun (Camb); 2015 Jan; 51(8):1453-6. PubMed ID: 25493296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery to the lymphatic system.
    Porter CJ
    Crit Rev Ther Drug Carrier Syst; 1997; 14(4):333-93. PubMed ID: 9450175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature.
    Herringson TP; Altin JG
    Int J Pharm; 2011 Jun; 411(1-2):206-14. PubMed ID: 21443937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery.
    Shen CY; Wu MC; Tyan YS; Ou CH; Chen TY; Wong HF
    Clin Radiol; 2012 Feb; 67(2):182-4. PubMed ID: 22018802
    [No Abstract]   [Full Text] [Related]  

  • 19. Liposomal drug delivery system from laboratory to clinic.
    Kshirsagar NA; Pandya SK; Kirodian GB; Sanath S
    J Postgrad Med; 2005; 51 Suppl 1():S5-15. PubMed ID: 16519249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV.
    Lalanne M; Paci A; Andrieux K; Dereuddre-Bosquet N; Clayette P; Deroussent A; Ré M; Vassal G; Couvreur P; Desmaële D
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2237-40. PubMed ID: 17276686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.